-
1.发明授权Apparatus and method for implementing multi-traffic load monitoring and prediction 有权实现多业务负载监测和预测的装置和方法公开(公告)号：US07099674B2
公开(公告)日：2006-08-29
申请号：US10417562
申请日：2003-04-17
申请人： Xinxi Diao , Yi Xie , Jun Li
发明人： Xinxi Diao , Yi Xie , Jun Li
IPC分类号： H04Q7/20
CPC分类号： H04W24/00 , H04B17/26 , H04B17/318 , H04B17/336 , H04B17/3913
摘要： An apparatus and method for implementing multi-traffic load monitoring and prediction in a CDMA cellular mobile communication system includes a received signal strength indication (RSSI) measuring unit for measuring total interference power and processing a measured value to eliminate jitters; a parameter accounting or statistic unit for accounting for some traffic parameters associated to the load monitoring and prediction; a load monitoring unit for calculating the load monitoring based on the measured value and statistic results; and a load prediction unit for calculating an increased amount of an up link load after receiving or accessing new traffic and a total load value after receiving or accessing the new traffic based on parameters requested by the new traffic and calculation results transmitted in real time by the load monitoring unit.
摘要翻译： 一种用于在CDMA蜂窝移动通信系统中实现多业务负载监测和预测的装置和方法，包括用于测量总干扰功率并处理测量值以消除抖动的接收信号强度指示（RSSI）测量单元; 用于计算与负载监测和预测相关的一些流量参数的参数计算或统计单元; 负载监测单元，用于根据测量值和统计结果计算负荷监测; 以及负载预测单元，用于在接收或访问新业务之后计算上行链路负载的增加量，以及基于新业务请求的参数和接收到新业务后的总负载值，以及实时发送的计算结果 负载监控单元。
-
公开(公告)号：US20110065459A1
公开(公告)日：2011-03-17
申请号：US12558782
申请日：2009-09-14
申请人： Long Cheng , Yi Xie
发明人： Long Cheng , Yi Xie
CPC分类号： G06F3/017 , G06F3/04842 , G06F3/0488 , H04M1/7253 , H04M2250/22 , H04M2250/64 , H04W4/02 , H04W4/023 , H04W4/21
摘要： Content transfer involving a gesture is described. In an implementation, a method is implemented by a mobile communications device that includes recognizing a gesture input via a touchscreen of the mobile communications device that is indicative of a direction, the touchscreen including a display of content. One or more other mobile communications devices are located that are positioned, approximately, along the indicated direction of the gesture. A communication is formed to transfer the content to the located one or more other mobile communications devices.
摘要翻译： 描述涉及手势的内容传送。 在实现中，一种移动通信设备实现了一种方法，该移动通信设备包括通过移动通信设备的触摸屏识别指示方向的手势输入，所述触摸屏包括内容的显示。 定位一个或多个其它移动通信设备，其大致沿指示的手势方向定位。 形成通信以将内容传送到所定位的一个或多个其他移动通信设备。
-
3.发明授权Polypeptide human polyadenylation binding protein 20.13 and polynucleotide encoding it 失效多肽人多腺苷酸化结合蛋白20.13和编码它的多核苷酸公开(公告)号：US07049404B2
公开(公告)日：2006-05-23
申请号：US10362238
申请日：2001-08-20
CPC分类号： C07K14/47
摘要： Novel human polyadenylation binding Protein 20.13 and polynucleotide encoding it. The invention also concerns the process of producing the polypeptide by recombinant DNA technique, and methods for treating many diseases e.g. disorder of embryo development, growth developmental disturbant diseases etc. The invention also discloses antagonists against the polypeptide.
摘要翻译： 新型人多聚腺苷酸化结合蛋白20.13和编码它的多核苷酸。 本发明还涉及通过重组DNA技术生产多肽的方法，以及用于治疗许多疾病的方法，例如， 胚胎发育障碍，生长发育障碍疾病等。本发明还公开了抗多肽的拮抗剂。
-
4.发明申请Novel polypeptide - human retinoic acid-responsive protein 53.57 and a polynucleotide encoding the same 审中-公开新型多肽 - 人视黄酸反应蛋白53.57和编码该多肽的多核苷酸公开(公告)号：US20060003375A1
公开(公告)日：2006-01-05
申请号：US11193473
申请日：2005-08-01
摘要： A novel polypeptide-human retinoic acid-responsive protein 53.57 and a polynucleotide encoding the same, as well as a method of producing the polypeptide by DNA recombinant technique. The present invention also discloses methods of using the polypeptide in treatment of various disease, such as arhythmia, bronchial asthma, peptic ulcer, diabetes mellitus, tumor, developmental deformation of embryo and so on. Also disclosed are antagonists against the polypeptide and the therapeutic use of the same.
摘要翻译： 一种新型多肽 - 人视黄酸反应蛋白53.57及其编码的多核苷酸，以及通过DNA重组技术生产多肽的方法。 本发明还公开了多种治疗各种疾病如心律失常，支气管哮喘，消化性溃疡，糖尿病，肿瘤，胚胎发育变形等的方法。 还公开了抗多肽的拮抗剂及其治疗用途。
-
5.发明授权Polypeptide-human SNARE protein 25 and a polynucleotide encoding the same 失效多肽 - 人类SNARE蛋白25和编码其的多核苷酸公开(公告)号：US06919431B1
公开(公告)日：2005-07-19
申请号：US10148125
申请日：2000-11-20
CPC分类号： C07K14/705 , A61K38/00
摘要： The present invention discloses a novel polypeptide-Human SNARE protein 25 and polynucleotide encoding the same, as well as a method of producing the polypeptide by DNA recombinant technology. The present invention also discloses methods of using the polypeptide in treatment of various diseases, such as malignant tumor, blood disease, HIV infection, immunological disease and various inflammations. The present invention also discloses an antagonist against the polypeptide and the therapeutic use of the same. The present invention also discloses the use of such polynucleotide encoding Human SNARE protein 25.
摘要翻译： 本发明公开了一种新型多肽 - 人类SNARE蛋白25和编码该多肽的多核苷酸，以及通过DNA重组技术生产该多肽的方法。 本发明还公开了使用该多肽治疗各种疾病如恶性肿瘤，血液病，HIV感染，免疫疾病和各种炎症的方法。 本发明还公开了抗多肽的拮抗剂及其治疗用途。 本发明还公开了编码人类SNARE蛋白25的多核苷酸的用途。
-
公开(公告)号：US06844323B2
公开(公告)日：2005-01-18
申请号：US10168626
申请日：2000-12-18
摘要： The present invention discloses a new polypeptide-calcitonin 11, the polynucleotide encoding it and a method producing the polypeptide by recombinant DNA technology. The present invention further discloses a method using the polypeptide to treat various disorders, e.g. malignant neoplasm, hematopathy, HIV infection and immunological disease and various inflammation etc. The present invention also discloses agonists of the polypeptide and their therapeutic uses. The present invention further discloses the use of the polynucleotide encoding the new calcitonin 11.
摘要翻译： 本发明公开了一种新的多肽降钙素11，其编码的多核苷酸和通过重组DNA技术产生多肽的方法。 本发明还公开了一种使用该多肽治疗各种疾病的方法，例如， 恶性肿瘤，血液病，HIV感染和免疫疾病以及各种炎症等。本发明还公开了多肽的激动剂及其治疗用途。 本发明还公开了编码新的降钙素11的多核苷酸的用途。
-
7.发明申请MINIMAL MOTIFS OF LINEAR B-CELL EPITOPES IN L1 PROTEIN FROM HUMAN PAPILLOMAVIRUS TYPE 58 AND THEIR APPLICATIONS 失效来自人类羊毛病菌类型58的L1蛋白质中的线性B细胞外膜的最小运动及其应用公开(公告)号：US20130202632A1
公开(公告)日：2013-08-08
申请号：US13364952
申请日：2012-02-02
申请人： Wanxiang Xu , Shaohua Gu , Yaping He , Chaoneng Ji , Haiping Tang , Jian Wang , Zhida Sun , Yi Xie
发明人： Wanxiang Xu , Shaohua Gu , Yaping He , Chaoneng Ji , Haiping Tang , Jian Wang , Zhida Sun , Yi Xie
CPC分类号： A61K39/12 , C07K5/1008 , C07K5/1019 , C07K5/1021 , C07K5/1024 , C07K16/084 , C12N2710/20022 , C12N2710/20034
摘要： Minimal Motifs of linear B-cell epitopes in L1 structure protein from human papillomavirus type 58 (HPV 58) and their applications are disclosed. Eighteen linear epitope motifs and their extended 8-mer peptides in the L1 protein from HPV 58 are described, which can be used as antigens separately or in combination to specifically detect the serum from subjects with HPV 58 infection, or to develop preventive or therapeutic multi-epitope peptide vaccines against HPV 58 by inducing humoral immunity. Of the eighteen B-cell epitope motifs, ten of them are 100% conservative and one is highly conservative among many homologous proteins of high-risk HPVs. They can be used as candidate “universal” epitopes to develop preventive or therapeutic HPV vaccines. The amino acid sequences of the epitope motifs and the 8-mer peptide formula of the invention are shown below in SEQ ID No. 1-2, 2B, 3, 3B, 4-18, 18B, 19, 19B, and 20-32.
摘要翻译： 公开了来自人乳头状瘤病毒58型（HPV 58）的L1结构蛋白中线性B细胞表位的最小基序及其应用。 描述了来自HPV58的L1蛋白中的十八个线性表位基序及其延伸的8聚体肽，其可以单独或组合用作抗原，以特异性检测来自具有HPV58感染的受试者的血清，或用于开发预防或治疗多 - 通过诱导体液免疫来抗HPV 58的表面肽疫苗。 在十八个B细胞表位图案中，其中十个是100％保守的，一个在高风险HPV的许多同源蛋白中是高度保守的。 它们可以用作候选“通用”表位，以开发预防或治疗性HPV疫苗。 本发明的表位基序和8-聚体肽配方的氨基酸序列如SEQ ID No.1-2,2B，3,3B，4-18,18B，19,19B和20-32所示 。
-
8.发明授权Polypeptide, human vacuolar H+ -ATPase C subunit 42 and polynucleotide encoding it 失效多肽，人液泡H + -ATPase C亚基42和编码它的多核苷酸公开(公告)号：US06994996B1
公开(公告)日：2006-02-07
申请号：US10111573
申请日：2000-10-27
CPC分类号： C12N9/14
摘要： The invention discloses a novle human vacuolar H+-ATPase C subunit 42 and a polynucleotide encoding it. The invention also concerns a process of producing the polypeptide by recombinant DNA techniques. Methods are also disclosed for treating many diseases, e.g. malignant tumors, hemopathies, HIV infections, immune diseases and inflammations utilizing the ploypeptide. The invention discloses antagonists of the polypeptide and therapeutics comprising the same. The invention also discloses the uses of the polynucleotide, which encodes the human vacuolar H+-ATPase C subunit 42.
摘要翻译： 本发明公开了一种novle人液泡H + -ATPase C亚基42和编码它的多核苷酸。 本发明还涉及通过重组DNA技术产生多肽的方法。 还公开了治疗许多疾病的方法，例如。 恶性肿瘤，血液病，艾滋病毒感染，免疫疾病和利用双肽的炎症。 本发明公开了多肽的拮抗剂和包含其的治疗剂。 本发明还公开了编码人液泡H + -ATP酶C亚基42的多核苷酸的用途。
-
公开(公告)号：US20050225904A1
公开(公告)日：2005-10-13
申请号：US11155911
申请日：2005-06-16
申请人： Ming Yao , Masashi Shiraishi , Yi Xie
发明人： Ming Yao , Masashi Shiraishi , Yi Xie
CPC分类号： G11B5/4853 , G11B5/4826 , G11B5/5552 , G11B5/56 , Y10T29/42 , Y10T29/49025 , Y10T29/49027 , Y10T29/49032
摘要： A micro-actuator that reduces suspension tongue stiffness and a method of manufacturing the micro-actuator are disclosed. In one embodiment, the micro-actuator has a base piece with two arms extending from the base piece. The electric contact pads for the arms are situated on the exterior of the arms at the end opposite the base piece. In one embodiment, the electric contact pads are electrically coupled to the same connection plate that the magnetic read/write head is coupled to, reducing the number of connection traces.
摘要翻译： 公开了一种降低悬架舌刚度的微致动器以及微致动器的制造方法。 在一个实施例中，微致动器具有基部件，其具有从基部件延伸的两个臂。 用于臂的电接触垫位于与基部相对的端部处的臂的外部。 在一个实施例中，电接触焊盘电耦合到磁读/写头耦合到相同的连接板，减少连接迹线的数量。
-
10.发明申请Polypeptide-human zinc finger protein fpm315-17 and the polynucleotide encoding it 审中-公开多肽 - 人锌指蛋白fpm315-17和编码它的多核苷酸公开(公告)号：US20050069871A1
公开(公告)日：2005-03-31
申请号：US10311632
申请日：2001-06-18
摘要： A new polypeptide, human zinc finger protein FPM315-17, the polynucleotide encoding it and a method for producing the polypeptide by DNA recombinant technology. The present invention further discloses a method for using the polypeptide or polynucleotide for treating various disorders, e.g., various tumors, nervous system disorders, hemopathy, developmental disorders, and HIV infections. The present invention also discloses an antagonist of the polypeptide and its therapeutic application.
摘要翻译： 新的多肽，人锌指蛋白FPM315-17，其编码的多核苷酸以及通过DNA重组技术产生多肽的方法。 本发明还公开了一种使用多肽或多核苷酸治疗各种疾病，例如各种肿瘤，神经系统疾病，血液病，发育障碍和HIV感染的方法。 本发明还公开了多肽的拮抗剂及其治疗应用。
-
-
-
-
-
-
-
-
-
搜索结果
31 条记录 (耗时 0.031 秒)
